Cite
HARVARD Citation
Conway, B. et al. (2016). C‐EDGE CO‐STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOID AGONIST THERAPY (OAT). Canadian Journal of Addiction. 7 (4), p. . [Online].